Learn how biohacking is unlocking human potential.
Publishers need to take responsibility for code they run on my systems.
Thoughts on "We are the people they warned you about."
Learn how the Defense Advanced Research Projects Agency (DARPA) has spurred significant advances in the promising field of synthetic biology.
New technology is allowing doctors to diagnose and treat heart disease faster and more efficiently.
Scale changes the problems of privacy, security, and honesty in fundamental ways.
Several new apps are making it easier for doctors and patients to conduct clinical trials.
CGMs are unique in the way consumers have taken it upon themselves to create modifications to medical devices.
The FDA is entering a new era of regulation as whole genome sequencing becomes more accessible to consumers.
Startups and individuals on the cusp of biological breakthroughs.
GV, Google's venture capital arm, is investing in several promising biotechnology startups.
Bioprinting, a technology that emerged from open source communities, has the potential to improve medical science.
Electronic waste is an economic and environmental problem, but citizen scientists can take action by using harvested sensors from discarded electronics.
Exciting new genetic testing technology has improved the speed and accuracy of cancer diagnosis.
There’s beauty in biology—and the biotech industry is ready to make a move
Shreya Thiagarajan describes the invaluable experience she gained while working in a local community lab.
The accelerator is helping scientists turn their moonshot visions into viable businesses, fast.
New technology is allowing researchers to use digitization to help detect cancer.
It's time to stop cursing the network we have and build the network we want.
It's time to rally in defense of the internet again.
The tools of defensive computing, whether they involve mascara and face paint or random autonomous web browsing, belong to the harsh reality we've built.
A look at the cutting-edge technology featured at the most recent IndieBio Demo Day.
Miroculus democratizes early cancer detection with an open research database and a digital microfluidic platform.
Everyday citizens are becoming empowered to contribute to modern medical science.
NemaMetrix’s ScreenChip collects live-animal, high-throughput C. elegans elecropharyngeograms (EPGs), which are an indication of overall organism health for drug development.
The O'Reilly Radar Podcast: The maturity of AI in enterprise, bridging the AI gaps, and what the U.S. can do with $4 trillion.
Julian Rubinfien discusses the Genes in Space contest and his winning experiment that will be sent to the International Space Station.
O'Reilly Radar Podcast: David Beyer on AI adoption challenges, the complexities of getting an AI ROI, and the dangers of hype.
A CRISPR kit to help engineers construct better tools.
The O'Reilly Radar Podcast: Turning personalization into a two-way conversation.
A look at three alternate natural sweeteners that could be safe for our health.
The O'Reilly Radar Podcast: The value humans bring to AI, guaranteed job programs, and the lack of AI productivity.
The O’Reilly Radar Podcast: AI on the hype curve, imagining nurturing technology, and gaps in the AI conversation.
The O'Reilly Radar Podcast: The art and science of fostering serendipity skills.
BioHTP explored the projects the biohacking community is tackling, how the community is organized, and where it's going.
This DIY initiative aims to genotype Pacific salmon to help sustain and improve salmon populations.
The O'Reilly Radar Podcast: Designing for mainstream AI, natural language interfaces, and the importance of reinventing yourself.
The O'Reilly Radar Podcast: Imbuing robots with magic, eschewing deception in AI, and problematic assumptions of human-taught reinforcement learning.
How I traced the falsity of one internet meme, and what that teaches us about how an algorithm might do it.
It isn’t just Facebook that has a fake news problem, and it isn’t just Donald Trump and kids in Macedonia who are using social media to send the news spinning wildly away from the truth.
The O'Reilly Radar Podcast: Big data for security, challenges in fraud detection, and the growing complexity of fraudster behavior.
The project was spurred by a U.S. Environmental Protection Agency plan to dredge and cap the waterway over the coming decade.
Events and gatherings for the biological revolution.
The O'Reilly Radar Podcast: Thinking critically about AI, modeling language, and overcoming hurdles.
Bringing biology to the design studio.
A new approach to solving the reproducibility crisis.
O'Reilly Radar Podcast: SNAFU Catchers, knowing how things work, and the proper response to system discrepancies.
The latest event revealed a pervading feeling that DIY biotech is maturing at an accelerating rate.
The O'Reilly Radar Podcast: Prediction algorithms, cognitive biases, and how our brains come online.
A look at the expanding biotech landscape at SXSW.
How Vulpine Designs is addressing the cellular equivalent of compiler problems.
The O'Reilly Radar Podcast: Navigating the increasing globalization of industry and commerce.
The O'Reilly Radar Podcast: perceptual robotics, post-evolutionary humans, and designing our future with intent.
The O'Reilly Radar Podcast: Bot hype, bot UX, and bots in the workplace.
BioBuilder promises a way forward for biology education.
In this O’Reilly Radar Podcast: The impact of minimal IoT product security and the case for new pro-security business models.
The Discovery System is a portable, personal DNA lab that anyone can use.
SCRN empowers researchers to easily access tools to analyze or share their data and analysis workflows.
The O'Reilly Radar Podcast: Natural language understanding and natural language processing applications, our future with chatbots, and open source indexing.
Community labs are the forefront of the DIYbio movement.